These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6288570)

  • 21. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio).
    Paque RE; Gauntt CJ; Nealon TJ
    Infect Immun; 1981 Jan; 31(1):470-9. PubMed ID: 6260666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against herpes virus and encephalomyocarditis virus encephalitis with a double-stranded RNA inducer of interferon.
    Catalano LW; Baron S
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):684-7. PubMed ID: 5414254
    [No Abstract]   [Full Text] [Related]  

  • 23. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.
    Field AK; Tytell AA; Lampson GP; Hilleman MR
    Proc Natl Acad Sci U S A; 1967 Sep; 58(3):1004-10. PubMed ID: 5233831
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiviral activity of N-phenyl-N'-aryl- or alkylthiourea derivatives in Coxsackie virus infections in mice.
    Galabov AS; Velichkova EH
    Antimicrob Agents Chemother; 1974 Jan; 5(1):1-8. PubMed ID: 4840444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.
    Rager-Zisman B; Allison AC
    J Gen Virol; 1973 Jun; 19(3):339-51. PubMed ID: 4723533
    [No Abstract]   [Full Text] [Related]  

  • 26. Late therapy of an arbovirus encephalitis in mice with interferon and interferon stimulators.
    Worthington M; Levy H; Rice J
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):638-43. PubMed ID: 4719449
    [No Abstract]   [Full Text] [Related]  

  • 27. Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator.
    Norris D; Loh PC
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):133-6. PubMed ID: 4683231
    [No Abstract]   [Full Text] [Related]  

  • 28. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.
    Woodruff JF; Woodruff JJ
    J Immunol; 1974 Dec; 113(6):1726-34. PubMed ID: 4610045
    [No Abstract]   [Full Text] [Related]  

  • 29. Virus myocardiopathy.
    Lerner AM; Wilson FM
    Prog Med Virol; 1973; 15():63-91. PubMed ID: 4572440
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus.
    Shore SL; Nahmias AJ; Starr SE; Wood PA; McFarlin DE
    Nature; 1974 Sep; 251(5473):350-2. PubMed ID: 4372535
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological destruction of herpes simplex virus I infected cells.
    Rager-Zisman B; Bloom BR
    Nature; 1974 Oct; 251(5475):542-3. PubMed ID: 4371311
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes.
    Lodmell DL; Niwa A; Hayashi K; Notkins AL
    J Exp Med; 1973 Mar; 137(3):706-20. PubMed ID: 4347596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA.
    Park JH; Baron S
    Science; 1968 Nov; 162(3855):811-3. PubMed ID: 4301068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis.
    Reyes MP; Lerner AM
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):333-8. PubMed ID: 1250870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of murine rabies after exposure: efficacy of polyriboinosinic-polyribocytidylic acid alone and in combination with three rabies vaccines.
    Harmon MW; Janis B
    J Infect Dis; 1975 Sep; 132(3):241-9. PubMed ID: 1159327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine.
    Baer GM; Shaddock JH; Moore SA; Yager PA; Baron SS; Levy HB
    J Infect Dis; 1977 Aug; 136(2):286-91. PubMed ID: 408427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effects of antiviral agents and humoral antibodies in experimental Herpesvirus hominis encephalitis.
    Cho CT; Feng KK
    Ann N Y Acad Sci; 1977 Mar; 284():321-34. PubMed ID: 280140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of adenine arabinoside and host defense factors in experimental infections due to Herpesvirus hominis.
    Cho CT; Feng KK
    J Infect Dis; 1977 Mar; 135(3):468-72. PubMed ID: 191543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic antiviral effects of adenine arabinoside and humoral antibodies in experimental encephalitis due to Herpesvirus hominis.
    Cho CT; Feng KK; Brahmacupta N
    J Infect Dis; 1976 Feb; 133(2):157-67. PubMed ID: 173763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer.
    Cho CT; Feng KK; McCarthy VP; Lenahan MF
    Infect Immun; 1982 Aug; 37(2):720-7. PubMed ID: 6288570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.